Most people born with congenital heart disease today survive well into adulthood, a dramatic shift from just a few decades ago when many did not make it past childhood. Current estimates place survival to adulthood above 95% for the overall population of people with CHD, though how far into adulthood and how well someone lives depends heavily on the specific heart defect, the quality of surgical repair, and whether they stay connected to specialized cardiac care. The picture is far more nuanced than a single life-expectancy number can capture, because “congenital heart disease” spans everything from a tiny hole in the heart that closes on its own to complex rearrangements of the heart’s chambers and blood vessels that require multiple open-heart surgeries before a child’s first birthday.
A Transformation in Survival
The change in life expectancy for people with CHD over the past half-century has been extraordinary. A Belgian population study tracking every child born with CHD between 1970 and 1992 found that survival to age 18 rose steadily across those decades, reaching about 89% for children born in the early 1990s, a significant jump compared with earlier cohorts.1PubMed. Temporal trends in survival to adulthood among patients born with congenital heart disease from 1970 to 1992 in Belgium Since then, surgical techniques and intensive care have continued to improve. More recent reviews put the overall survival rate to adulthood above 95%.2PubMed. Transition to Adult Congenital Heart Disease Care: A Review The result is that the adult CHD population is growing rapidly. There are now more adults living with congenital heart disease than children, and that gap widens every year.3PubMed Central. Transitional Care for Adult Patients with Congenital Heart Disease
These numbers are population-wide averages, though, and they smooth over enormous variation. A person born with a small atrial septal defect that was closed in childhood has an essentially normal life expectancy. A person born with a single-ventricle heart who underwent a Fontan procedure faces a very different trajectory. The type of defect matters more than almost anything else when it comes to predicting how long someone will live.
How Outcomes Differ by Type of Defect
Tetralogy of Fallot, one of the more common complex defects, offers a useful reference point. A large cohort study of over 3,200 patients found that survival 25 years after complete surgical repair was about 95%.4PubMed Central. Long-term Outcomes of Tetralogy of Fallot: A Study From the Pediatric Cardiac Care Consortium That sounds excellent, and it is. But the picture shifts when you extend the timeline further. A study following patients out to 50 years after repair found cumulative survival of about 84% among those who survived the initial surgery, compared with 93% in the general population.5International Journal of Cardiology. Long term outcome after surgical tetralogy of Fallot repair at young age: Longitudinal follow-up up to 50 years after surgery So many people with repaired tetralogy of Fallot live into their 50s and beyond, but the gap with the general population grows over time. Almost nobody in that study reached the 50-year mark without needing at least one additional procedure: cumulative event-free survival at 50 years was just 9%, and about a third required pulmonary valve replacement.5International Journal of Cardiology. Long term outcome after surgical tetralogy of Fallot repair at young age: Longitudinal follow-up up to 50 years after surgery
Transposition of the great arteries, another major complex defect, has its own trajectory. The modern repair, called the arterial switch operation, has produced strong results: 20-year transplant-free survival sits around 82%. The older atrial switch procedures, which were standard before the late 1980s, have slightly lower long-term survival, and the divergence between the two approaches widens after about 10 years.6PubMed Central. Long-term Survival following Arterial vs. Atrial Switch in d-Transposition of the Great Arteries Adults who had the older procedure are now entering middle age, and they tend to need closer monitoring for heart rhythm problems and heart failure.
The most challenging group involves people with single-ventricle physiology, where the heart effectively has only one functioning pumping chamber. These patients typically undergo the Fontan procedure, which reroutes blood flow so the single ventricle can serve the body while blood returns passively to the lungs. Data from a national Australian and New Zealand registry show that 25-year survival after a Fontan is about 76%, depending on the type of surgical connection used. Newer techniques, such as lateral tunnels and extracardiac conduits, have better 10-year survival, around 97%, compared with older approaches.7PubMed. Redefining expectations of long-term survival after the Fontan procedure: twenty-five years of follow-up from the entire population of Australia and New Zealand However, the Fontan circulation is inherently non-physiological. Freedom from major complications 20 years out was about 70%, meaning nearly a third of patients had experienced heart failure, needed a transplant, or developed serious complications by that point.7PubMed. Redefining expectations of long-term survival after the Fontan procedure: twenty-five years of follow-up from the entire population of Australia and New Zealand
As Fontan patients push into their 40s and 50s, the complications accumulate. A study of Fontan patients beyond their fourth decade of life found that about 17% died over a median follow-up of five years, overwhelmingly from heart failure. Prior hospitalizations for heart failure and abnormal heart rhythms were strong predictors of who would deteriorate.8European Journal of Preventive Cardiology. Morbidity and mortality in adults with a Fontan circulation beyond the fourth decade of life These patients require lifelong, multi-organ surveillance because the Fontan circulation affects not just the heart but the liver, kidneys, and lymphatic system.9PubMed. Long Term Consequences of the Fontan Procedure and How to Manage Them
What Kills Adults With Congenital Heart Disease
Heart failure is the leading cause of death in adults with CHD, and it behaves differently in this population than in people who develop heart problems later in life.10PubMed. Heart failure in adults with congenital heart disease The underlying anatomy is abnormal from birth, and even after successful surgery the heart often carries residual abnormalities: leaky valves, scar tissue from prior procedures, or chambers that were never designed to do the job they were repaired to do. Over decades, these impose a cumulative burden. Heart failure can be subtle at first, and patients sometimes develop significant dysfunction before they notice symptoms, which is one reason regular follow-up is so important.
Sudden cardiac death is another major concern. In adults with CHD, it is linked to abnormal heart rhythms that arise from surgical scars, stretched heart muscle, or the structural quirks of the underlying defect. Risk factors include fast abnormal rhythms originating in the upper heart chambers, weak pumping function, and widening of the electrical signal on an ECG.11PubMed. Sudden cardiac death in adult congenital heart disease The triggers are diverse, ranging from metabolic shifts to inflammation, and the risk rises as patients age and their hearts accumulate more damage.12European Heart Journal. Sudden cardiac death in congenital heart disease
Eisenmenger syndrome, which develops when a large unrepaired heart defect causes irreversible damage to the lung blood vessels, carries a particularly grim prognosis. Survival from diagnosis at three, six, and nine years was about 73%, 50%, and 47% respectively in one study.13PubMed Central. Life span of patients with Eisenmenger syndrome is not superior to that of patients with other causes of pulmonary hypertension This condition is now far less common in high-income countries because defects are repaired early, but it remains a serious problem in parts of the world where access to pediatric heart surgery is limited.
The Gap Between What Patients Expect and What Doctors See
One of the most striking findings in recent research is how differently patients and their cardiologists view the same prognosis. A study of adults 40 to 53 years after heart surgery found that most patients with moderate-to-severe CHD believed their life expectancy was comparable to their healthy peers. Their cardiologists disagreed sharply: the doctors estimated that only about 20% of those patients actually had a life expectancy on par with the general population.14European Heart Journal Open. Life expectancy and end-of-life communication in adult patients with congenital heart disease, 40–53 years after surgery This disconnect existed for both men and women with complex disease.
This matters for practical reasons. If you believe your life expectancy is normal, you may not prioritize regular cardiac follow-up, advance care planning, or discussions about what to do if your heart deteriorates. The study raises the uncomfortable question of whether the medical system is failing to communicate prognosis clearly, or whether patients are (understandably) reluctant to absorb difficult information about their own futures. Either way, it highlights the value of honest, ongoing conversations between patients and their heart teams.
Why Staying Connected to Specialized Care Is So Important
Perhaps the most actionable finding for anyone with CHD is that where you get your care matters enormously. A study from the UK found that receiving care at a specialized adult congenital heart disease center, rather than from a general cardiologist or primary care physician, was independently associated with a roughly 22% lower risk of death. For patients with severe defects, the benefit was even more dramatic, with specialized care linked to a 62% lower risk of dying.15PubMed. Specialized adult congenital heart disease care: the impact of policy on mortality A separate population-based study confirmed this pattern, finding that adults with CHD who were followed by a cardiologist had significantly lower mortality and fewer major complications than those seen only by primary care providers.16European Heart Journal. Lack of specialist care is associated with increased morbidity and mortality in adult congenital heart disease: a population-based study
Despite these data, many adults with CHD drift away from specialized care. The transition from pediatric to adult cardiology is a well-known weak point. Patients leave their childhood cardiologist, feel well, and do not find or seek out an adult congenital heart disease specialist. Years or even decades can pass without monitoring, during which silent problems like valve deterioration or weakening heart function can develop unchecked.17Congenital Heart Disease. Loss to Specialized Cardiology Follow-Up in Adults Living with Congenital Heart Disease If you were born with CHD of any complexity beyond the most trivial, maintaining regular contact with a specialist is one of the single best things you can do for your long-term survival.
Exercise and Physical Activity
One of the most persistent misconceptions about living with CHD is that exercise is dangerous. Many adults with CHD were told as children to sit out gym class or avoid sports, and that advice sticks. Fear and misinformation remain common barriers to physical activity in this population, even though the evidence shows that lower fitness is actually associated with worse outcomes.18PubMed. Risks and Benefits of Exercise Training in Adults With Congenital Heart Disease
A meta-analysis of nine trials involving over 400 adults with CHD found that exercise training significantly improved aerobic fitness, exercise capacity, and exercise duration, with no major adverse events reported.19Journal of Cardiopulmonary Rehabilitation and Prevention. Exercise Training in Adults With Congenital Heart Disease The improvements are meaningful because fitness in CHD tracks with both physical health and psychological well-being. Current guidance emphasizes that almost everyone with CHD should receive an individualized exercise prescription, and that recreational and even competitive sports are feasible for many patients.20PubMed Central. Exercise, prescription and training in ACHD The specifics depend on the defect and its repair, which is yet another reason to stay in touch with a specialist who can give you an honest assessment of what your heart can handle.
Pregnancy With Congenital Heart Disease
Pregnancy places significant demands on the heart, increasing blood volume by roughly 40-50% and raising cardiac output substantially. For women with CHD, this creates real risk that varies enormously by defect type. Some women with simple, well-repaired defects go through pregnancy without issues. Others with complex anatomy, poor heart function, or pulmonary hypertension face risks that can be life-threatening.
Several risk stratification tools exist, the most widely used being the modified WHO classification, which groups women into risk categories based on their underlying diagnosis and functional status. The WHO system appears to perform best specifically in women with congenital heart disease, and combining it with clinical characteristics helps build an individualized risk picture.21PubMed. Pregnancy in congenital heart disease: risk prediction and counselling Pre-conception counseling at a specialized center is strongly recommended, because understanding the odds of complications for both mother and baby allows informed decisions about whether and how to pursue pregnancy.22JAMA Network Open. Association of Adult Congenital Heart Disease With Pregnancy, Maternal, and Neonatal Outcomes The worst outcomes tend to cluster in women with severe pulmonary hypertension or very poor ventricular function, conditions where pregnancy is often advised against altogether.
Brain Health and Cognitive Effects
Living longer with CHD has revealed a set of challenges that nobody was talking about when the first generation of surgical survivors were children. One of the most underappreciated is the effect on brain function. CHD can affect the brain across the lifespan, through a combination of altered blood flow before and after birth, the effects of open-heart surgery and cardiopulmonary bypass, and ongoing low-grade oxygen delivery issues.23PubMed Central. Brain in Congenital Heart Disease Across the Lifespan: The Cumulative Burden of Injury
Adults with severe CHD show measurable differences in cognitive function. One study found that people with severe defects scored lower than population norms in areas including processing speed, complex attention, and reaction time, and that the number of surgeries a person had undergone was strongly linked to worse executive functioning.24PubMed. Neurocognitive and executive functioning in adult survivors of congenital heart disease Interestingly, those with moderate-complexity defects showed no significant differences from the general population on the same tests, suggesting the cognitive burden scales with disease severity and surgical exposure.
Even adults with simple defects that were closed in childhood are not entirely off the hook. A controlled study comparing such patients against healthy peers found lower scores on IQ measures, verbal memory, visual memory, executive function, and social recognition.25PubMed Central. Neuropsychological Status and Structural Brain Imaging in Adults With Simple Congenital Heart Defects Closed in Childhood The differences are not necessarily disabling for most people, but they can affect daily life in ways that show up as difficulties with organization, attention, or learning new material. Recognizing this risk means it can be screened for and addressed with appropriate support.
Advances Extending the Horizon
Several developments are actively pushing survival further. Transcatheter valve replacement, a procedure that implants a new heart valve through a blood vessel rather than requiring open-heart surgery, has become a viable option for many adults with CHD who need valve replacements. A large single-center experience at the Mayo Clinic involving 341 adults with CHD who received transcatheter valves reported a 10-year mortality rate of about 13%.26PubMed Central. Transcatheter Valve Replacement in Adults With Congenital Heart Disease-The Mayo Clinic Experience This matters because many CHD patients face the prospect of multiple valve replacements over a lifetime. Being able to replace a valve without cracking the chest open again reduces surgical risk and recovery time, especially for someone who has already had several operations.27PubMed. Transcatheter Pulmonary Valve Replacement in Patients With Congenital Heart Disease
Heart transplantation remains the last resort for patients whose hearts are failing despite all other interventions. Outcomes for CHD patients undergoing heart transplantation have been improving, with one-year survival for heart-only recipients rising from about 73% to 91% in more recent surgical eras.28PubMed Central. A New Era of Cardiothoracic Transplantation in Adults With Congenital Heart Disease However, the data also underscore how important transplant access is: in one cohort, roughly 61% of CHD patients referred for transplant but not listed died, compared with about 23% of those who actually received a transplant.29PubMed. Characteristics and Outcomes of a Single-Centre Cohort of Adult Congenital Heart Disease Patients Referred for Heart Transplant The complex anatomy of congenital heart patients makes transplant surgery technically harder, which limits how many centers are willing and able to perform it.
Cancer Risk From Cumulative Medical Radiation
An underappreciated long-term consequence of CHD is elevated cancer risk from the medical radiation accumulated over a lifetime of cardiac imaging and catheterization procedures. By the time they are 15 to 20 years old, many CHD patients have already absorbed cumulative radiation doses equivalent to 1,000 to 2,000 chest X-rays.30PubMed Central. Congenital Heart Disease and the Risk of Cancer: An Update on the Genetic Etiology, Radiation Exposure Damage, and Future Research Strategies Children are particularly vulnerable to the cancer-causing effects of radiation, with risk estimates three to four times higher per unit of radiation than for adults.
A large study estimated that the cumulative incidence of cancer among adults with CHD reached about 15% by age 64. Crucially, cumulative radiation exposure from cardiac procedures was independently associated with cancer risk, and there appeared to be a dose-response relationship: patients in the highest percentiles of cumulative radiation had relative risk increases above 60%.31PubMed. Exposure to Low-Dose Ionizing Radiation From Cardiac Procedures and Malignancy Risk in Adults With Congenital Heart Disease32American Journal of Epidemiology. Flexible Modeling of the Association Between Cumulative Exposure to Low-Dose Ionizing Radiation From Cardiac Procedures and Risk of Cancer in Adults With Congenital Heart Disease This does not mean people with CHD should refuse necessary imaging. It does mean that care teams should think carefully about minimizing unnecessary radiation, using alternative imaging modalities like MRI or ultrasound when possible, and monitoring long-term survivors for cancer alongside their cardiac issues.
Where You Live Changes Everything
Global data show that survival with CHD has improved almost everywhere, but the gap between wealthy and poor regions remains vast. Overall survival improved from about 23% to 27% between 2005 and 2020 worldwide, with the sharpest gains in countries with high socioeconomic development. In those wealthier nations, the gap in life expectancy between men and women with CHD had narrowed to just over a year by 2020. In low-development regions, the gap remained nearly nine years.33PubMed. Global survival trends in congenital heart disease: Temporal, regional, and sex disparities from global burden of disease analyses
Even within wealthy countries, disparities persist. Race, ethnicity, insurance status, family income, and geographic distance from a surgical center all independently affect outcomes for children born with CHD.34PubMed Central. Addressing Disparities in Pediatric Congenital Heart Disease: A Call for Equitable Health Care A baby born with the same defect can have meaningfully different survival odds depending on whether they happen to be born near a high-volume surgical center with experienced pediatric cardiac surgeons, or in a rural area hours from one. These disparities carry forward into adulthood, compounding over a lifetime.
Genetic Syndromes and Their Influence
About a third of adults with CHD at one specialized center had at least one additional congenital or neurodevelopmental condition, and those patients were far more likely to have an identified genetic or syndromic diagnosis.35Frontiers in Genetics. Genetic investigation and diagnosis in adults with congenital heart disease with or without structural or neurodevelopmental comorbidity Conditions like Down syndrome, DiGeorge syndrome (22q11.2 deletion), Turner syndrome, and others carry their own trajectories that interact with the heart defect in complex ways. A genetic diagnosis can influence which surgeries are offered, how the heart recovers, and what other organ systems need monitoring. Genetic abnormalities were also identified as a significant predictor of decreased long-term survival after tetralogy of Fallot repair.4PubMed Central. Long-term Outcomes of Tetralogy of Fallot: A Study From the Pediatric Cardiac Care Consortium Yet roughly 20% of adults with CHD who had additional congenital or developmental conditions had never received genetic testing or referral, representing a missed opportunity to inform their care.
For adults with CHD considering having children, genetics also matters in a different way. Some forms of congenital heart disease have a hereditary component, and genetic counseling can help prospective parents understand the chances of passing a heart defect to their children. The recurrence risk varies by the specific defect and whether a known genetic cause has been identified, but in general the overall chance of a parent with CHD having a child with some form of heart defect is higher than the background population rate of about 1 in 100 births.